Clinical Trial Update: An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6 [NA]

View source ↗

Summary

A clinical trial investigating imaging in estrogen receptor-negative breast cancer by targeting αvβ6 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Queen Mary University of London | Conditions: Breast Cancer | NA | Status: WITHDRAWN